Neuropace, Inc. (NPCE) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

22/25

Growth 5 Margin 5 Expansion 4 Platform 5 Financial 3

latest quarter score

Earnings Reports

22
Neuropace (NPCE) Q2 2026: RNS Revenue Grows 21%, AI Tools Enhance Clinical Adoption
August 12, 2026
15
NeuroPace (NPCE) Q1 2026: RNS System Grows 20% as AI Roadmap, IGE Expansion Drive Guidance Lift
May 13, 2026
20
NeuroPace (NPCE) Q4 2025: RNS System Revenue Jumps 26% as Core Growth Engine Accelerates
March 04, 2026
21
NeuroPace (NPCE) Q3 2025: RNS Revenue Jumps 31% as Platform Shift Accelerates Margin Expansion
November 05, 2025
15
NeuroPace (NPCE) Q2 2025: Gross Margin Rises to 77.1% as RNS Platform Momentum Accelerates
August 12, 2025
19
NeuroPace (NPCE) Q1 2025: RNS-Driven 24% Revenue Growth Anchors Margin Expansion and Portfolio Pivot
July 07, 2025

Browse all companies